Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Aastrom Biosciences to Present at BIO Investor Forum Ann Arbor, Michigan, October 12, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, will be presenting at the 2006 BIO Investor Forum.
ANN ARBOR, Mich., Oct 30, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that Gerald D. Brennan, Vice President, Administrative and Financial Operations and Chief Financial Officer and Elmar R.
ANN ARBOR, Mich., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following webcast: What: Aastrom Biosciences, Inc., Third
ANN ARBOR, Mich., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast: What: Aastrom Biosciences, Inc., Third
ANN ARBOR, Mich., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following webcast: What: Aastrom Biosciences, Inc., Second
ANN ARBOR, Mich., March 6, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast: What: Aastrom Biosciences, Inc.,
ANN ARBOR, Mich., May 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast: What: Aastrom Biosciences, Inc., First
ANN ARBOR, Mich., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, will hold a Research and Development Day for investors on November
Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, September 7, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call tomorrow, Wednesday, September 8, 2004 at 11:00 a.m. (EDT).